Corrigendum to: “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia”

Abstract

The author has identified an error in the author’s name in an article titled “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia,” published in Anti-Cancer Agents in Medicinal Chemistry, 2022, 18, 3050-3061 [1]. Details of the error and a correction are provided here. ORIGINAL: Andre Yohan^{1 1}Department of Pharmaceutical Sciences, School of Pharmacy, MCPHS University, 19 Foster Street, Worcester, MA 01608, USA CORRECTED: Andre Yonan^{1 1}Department of Pharmaceutical Sciences, School of Pharmacy, MCPHS University, 19 Foster Street, Worcester, MA 01608, USA We regret the error and apologize to readers. The original article can be found online at: https://www.benthamscience.com/article/122906